A Tupaia paramyxovirus vector system for targeting and transgene expression

Area of Science:

• Virology
• Molecular Biology
• Gene Therapy

Background:

• Paramyxoviridae viruses are significant pathogens and utilized in gene therapy and cancer treatment.
• Tupaia paramyxovirus (TPMV) does not infect human cells, and existing neutralizing antibodies do not cross-react with it.

Purpose of the Study:

• To create a novel vector system for generating infectious Tupaia paramyxovirus (TPMV).
• To enable the insertion of additional genes and antibody-based targeting into the TPMV vector.
• To demonstrate the potential of this vector system for basic research and therapeutic applications.

Main Methods:

• Development of a de novo vector system for TPMV generation.
• Insertion of additional genes into the TPMV vector.
• Incorporation of antibody single-chain variable fragments for targeted cell entry.

Main Results:

• The recombinant TPMV vector system was successfully generated.
• The modified TPMV specifically infects cells engineered to express a targeted receptor.
• The recombinant TPMV demonstrated replication in human cells, overcoming previous limitations.

Conclusions:

• The developed TPMV vector system is a versatile tool for manipulating and utilizing TPMV.
• This system overcomes the natural host range limitations of TPMV, enabling its application in human cells.
• The vector system holds promise for advancing both fundamental virological research and developing novel therapeutic strategies.